IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.9962
-0.0938 (-8.61%)
At close: Apr 1, 2025, 4:00 PM
0.9651
-0.0311 (-3.12%)
After-hours: Apr 1, 2025, 7:52 PM EDT

IO Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-95.49-86.08-71.46-67.88-12.04
Upgrade
Depreciation & Amortization
0.850.760.540-
Upgrade
Stock-Based Compensation
6.538.067.041.790.06
Upgrade
Other Operating Activities
3.59-0.33-0.0426.221.87
Upgrade
Change in Accounts Payable
0.78-0.130.083.41-0.48
Upgrade
Change in Other Net Operating Assets
1.45.994.12-4.180.62
Upgrade
Operating Cash Flow
-82.35-71.74-59.73-40.65-9.96
Upgrade
Capital Expenditures
-0.04-0.32-0.69-0.15-
Upgrade
Investing Cash Flow
-0.04-0.32-0.69-0.15-
Upgrade
Issuance of Common Stock
-75.06-115.12-
Upgrade
Other Financing Activities
--3.2--12.11-0.01
Upgrade
Financing Cash Flow
-71.86-252.955.1
Upgrade
Foreign Exchange Rate Adjustments
-0.770.8-8.52-3.760.41
Upgrade
Net Cash Flow
-83.160.6-68.94208.39-4.44
Upgrade
Free Cash Flow
-82.39-72.06-60.42-40.8-9.96
Upgrade
Free Cash Flow Per Share
-1.25-1.66-2.10-9.41-56.19
Upgrade
Levered Free Cash Flow
-55.83-42.19-33.5-25.08-6.09
Upgrade
Unlevered Free Cash Flow
-55.83-42.19-33.32-24.85-6.08
Upgrade
Change in Net Working Capital
-2.85-6.47-4.430.72-0.2
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q